Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation, an Observational Study

NCT07346820 is registered in ClinicalTrials.gov with Umeå University as lead sponsor.

NCT NCT07346820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07346820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation, an Observational Study
Lead sponsor
Umeå University
Phase
Observational
Overall status
Not yet recruiting
Start date
February 1, 2026
Completion date
December 31, 2036
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

receptors, antigen, b-cel, stem cell transplantation, hematopoietic, v(d)j recombination